WELLS FARGO & COMPANY/MN - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,293,057
-19.6%
343,272
+1.0%
0.00%0.0%
Q2 2023$2,851,559
+5.6%
339,876
+25.0%
0.00%0.0%
Q1 2023$2,699,401
+22.0%
271,843
-14.5%
0.00%0.0%
Q4 2022$2,212,215
+33.4%
317,847
+2.4%
0.00%0.0%
Q3 2022$1,658,000
+25.4%
310,406
-6.3%
0.00%
Q2 2022$1,322,000
-10.1%
331,357
+0.2%
0.00%
Q1 2022$1,470,000
+55.2%
330,537
+39.7%
0.00%
Q4 2021$947,000
-58.4%
236,640
-8.8%
0.00%
-100.0%
Q3 2021$2,277,000
+42.8%
259,461
+84.2%
0.00%
Q2 2021$1,595,000
+79.8%
140,828
+88.6%
0.00%
Q1 2021$887,000
+1674.0%
74,676
+929.6%
0.00%
Q4 2020$50,000
+2400.0%
7,253
+2960.3%
0.00%
Q3 2020$2,0000.0%237
-54.0%
0.00%
Q2 2020$2,000
-95.1%
515
-96.9%
0.00%
Q1 2020$41,000
-60.2%
16,751
-5.8%
0.00%
Q4 2019$103,000
-59.6%
17,790
-63.3%
0.00%
Q3 2019$255,000
-0.8%
48,511
+13.5%
0.00%
Q2 2019$257,000
-32.9%
42,736
+0.8%
0.00%
Q1 2019$383,000
+3.0%
42,408
-5.6%
0.00%
Q4 2018$372,000
+53.1%
44,900
+155.9%
0.00%
Q3 2018$243,000
+82.7%
17,545
+4.2%
0.00%
Q2 2018$133,000
+22.0%
16,838
+15.9%
0.00%
Q1 2018$109,000
+18.5%
14,531
+7.3%
0.00%
Q4 2017$92,00013,5400.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders